Literature DB >> 17804204

Early-onset rhabdomyolysis related to daptomycin use.

Samir J Patel, Tobias C Samo, Wadi N Suki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17804204     DOI： 10.1016/j.ijantimicag.2007.07.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  6 in total

Review 1.  Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Authors:  Rasmus V Rasmussen; Vance G Fowler; Robert Skov; Niels E Bruun
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

2.  Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens.

Authors:  Andres Beiras-Fernandez; Ferdinand Vogt; Ralf Sodian; Florian Weis
Journal:  Infect Drug Resist       Date:  2010-08-30       Impact factor: 4.003

3.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

4.  A case report and literature review of daptomycin-induced liver injury.

Authors:  Alena Janda; Mather R D Jogendra
Journal:  IDCases       Date:  2018-09-01

5.  Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Chengwen Teng; Courtney Baus; James P Wilson; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-10-15       Impact factor: 3.738

Review 6.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.